Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NTNU Intranasal Naloxone Trial - a Double Blinded, Double Dummy, Randomized Controlled Trial of Intranasal Naloxone for Pre-hospital Use

NCT03518021 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT03518021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03518021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NTNU Intranasal Naloxone Trial - a Double Blinded, Double Dummy, Randomized Controlled Trial of Intranasal Naloxone for Pre-hospital Use
Lead sponsor
Norwegian University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
May 15, 2018
Completion date
October 6, 2020
Enrollment
286 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, overdose